VCIM
Velan Capital Investment Management Portfolio holdings
AUM
$99.9M
This Quarter Return
+5.48%
1 Year Return
+37.46%
3 Year Return
+659.14%
5 Year Return
–
10 Year Return
–
AUM
$94.3M
AUM Growth
+$94.3M
(-12%)
Cap. Flow
-$7.65M
Cap. Flow
% of AUM
-8.1%
Top 10 Holdings %
Top 10 Hldgs %
88.82%
Holding
29
New
5
Increased
6
Reduced
3
Closed
6
Top Buys
| 1 |
RDUS
Radius Health, Inc.
RDUS
|
$3.63M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
$2.38M |
| 3 |
QIPT
Quipt Home Medical
QIPT
|
$1.4M |
| 4 |
ALIM
Alimera Sciences, Inc.
ALIM
|
$1.02M |
| 5 |
Healthcare Services Group
HCSG
|
$871K |
Top Sells
| 1 |
ATRS
Antares Pharma, Inc.
ATRS
|
$5.52M |
| 2 |
Lantheus
LNTH
|
$3.39M |
| 3 |
RAPT Therapeutics
RAPT
|
$2.42M |
| 4 |
SNCE
Science 37 Holdings, Inc. Common Stock
SNCE
|
$1.91M |
| 5 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
$1.89M |
Sector Composition
| 1 | Healthcare | 78.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
1
DELISTED
Radius Health, Inc.
RDUS
| $18.4M | 18.63% | 1,771,500 +350,000 | +25% | +$3.63M |
|
|
2
Lantheus
LNTH
$3.73B
| $17.7M | 17.99% | 268,658 -51,342 | -16% | -$3.39M |
|
3
ADMA Biologics
ADMA
$4.12B
| $12M | 12.2% | 6,073,598 +250,800 | +4% | +$497K |
|
4
Immunocore
IMCR
$1.62B
| $10.9M | 11.1% | 293,385 | – | – |
|
|
OPTN
5
DELISTED
OptiNose
OPTN
| $7.32M | 7.43% | 2,000,000 | – | – |
|
6
Jasper Therapeutics
JSPR
$45.5M
| $5.48M | 5.56% | 3,219,036 | – | – |
|
7
TELA Bio
TELA
$70.5M
| $3.49M | 3.54% | 498,238 +46,838 | +10% | +$328K |
|
8
The Oncology Institute
TOI
$318M
| $3.04M | 3.08% | 600,000 | – | – |
|
|
9
Healthcare Services Group
HCSG
$1.13B
| $3.01M | 3.06% | 173,000 +50,000 | +41% | +$871K |
|
|
10
BioCryst Pharmaceuticals
BCRX
$1.74B
| $2.38M | 2.42% | +225,000 | New | +$2.38M |
|
|
CFMS
11
DELISTED
Conformis, Inc. Common Stock
CFMS
| $1.82M | 1.85% | 5,156,406 +511,899 | +11% | +$181K |
|
12
Sonida Senior Living
SNDA
$488M
| $1.74M | 1.76% | 82,832 | – | – |
|
|
QIPT
13
Quipt Home Medical
QIPT
$114M
| $1.4M | 1.42% | +302,100 | New | +$1.4M |
|
14
Rezolute
RZLT
$619M
| $1.29M | 1.31% | 400,000 +100,000 | +33% | +$323K |
|
15
Caribou Biosciences
CRBU
$174M
| $1.14M | 1.16% | 210,695 | – | – |
|
|
ALIM
16
DELISTED
Alimera Sciences, Inc.
ALIM
| $1.02M | 1.04% | +187,001 | New | +$1.02M |
|
|
NYXH
17
Nyxoah
NYXH
$234M
| $837K | 0.85% | 90,997 -71,969 | -44% | -$662K |
|
18
Xenon Pharmaceuticals
XENE
$2.98B
| $608K | 0.62% | +20,000 | New | +$608K |
|
|
SNCE
19
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $441K | 0.45% | 219,510 -953,151 | -81% | -$1.91M |
|
|
HZNP
20
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $237K | 0.24% | +2,967 | New | +$237K |
|
|
NKGNW
21
DELISTED
NKGen Biotech, Inc. Warrants
NKGNW
| $5K | 0.01% | 20,000 | – | – |
|
|
SLGCW
22
DELISTED
SomaLogic, Inc. Warrant
SLGCW
| $2K | ﹤0.01% | 2,060 | – | – |
|
|
23
RAPT Therapeutics
RAPT
$188M
| – | – | -110,000 | Closed | -$2.42M |
|
|
TSVT
24
DELISTED
2seventy bio
TSVT
| – | – | -23,657 | Closed | -$404K |
|
25
Viatris
VTRS
$12.3B
| – | – | -100,000 | Closed | -$1.09M |
|